As the field of HIV continues to advance, with new antiretroviral therapy (ART) regimens, an aging population with comorbidities, and additional considerations for special populations, clinicians must remain up to date on all areas of treatment. This Phone-a-Friend series will cover multiple patient populations and clinic scenarios, including long-acting injectable ART, the future of ART, comorbidities, and numerous special populations, with each episode presented as an interactive discussion between 2 faculty. Modules are moderated by Dr. Onyema Ogbuagu or Dr. Laura Waters. Check back regularly in 2025 for new episodes! 

 

This activity is provided by Integritas Communications (ACCME Credit).

This activity is jointly provided by Global Education Group (Global) and Integritas Communications (ANCC Credit).

This educational activity is supported by an independent medical education grant from Gilead Sciences, Inc.

modules
Webcast Series 
0.25 CME/CE

Evolving Best Practices for LAI Implementation

Begin Activity
Webcast Series 
0.25 CME/CE

Addressing Weight Gain in People With HIV in the GLP-1 RA Era

Begin Activity
Webcast Series 
0.25 CME/CE

The Future of ART: Broadly Neutralizing Antibodies (bNabs) and 2-Drug Regimens

Begin Activity
available resources
linked resources
Suggested Reading
A Phone-a-Friend Peer Consult Series™

Answers to Everyday Practice Challenges in HIV Medicine:

A Phone-a-Friend Peer Consult Series—Volume 3

view resource